Archived Medical News Stories

RSSArchived Pharmaceutical News Stories - August 2009

Date Title Comments Rating
2009-08-31 MRRI research study to investigate how zolpidem might restore consciousness for patients in the vegetative state 0 5
2009-08-31 Walgreens to provide flue shots faster and easier this season 1 None
2009-08-31 Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference 1 3.2
2009-08-31 Takeda visits managed care professionals to promote its two new drugs 0 None
2009-08-31 Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program 0 None
2009-08-31 Tianyin Pharmaceutical to discuss its diversified product portfolio at the Rodman & Renshaw Annual Global Investment Conference 0 None
2009-08-31 New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration 0 5
2009-08-31 Doxorubicin granted orphan drug designation by the FDA 0 None
2009-08-31 IntelGenx Technologies shareholder conference call to update shareholders on CPI-300 0 None
2009-08-31 Nuevolution partners with Novartis for drug research 0 None
2009-08-31 FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients 0 None
2009-08-31 Oral dabigatran etexilate reduces the risk of stroke and systemic embolism 0 5
2009-08-30 Intermediate dosages of otamixaban reduce acute coronary complications 0 None
2009-08-29 Research and Markets launches new report on the Worldwide Biological Product Manufacturing industry 0 None
2009-08-29 Court reverses the summary judgement decision on ANDA Patent litigation between Ortho McNeil and Caraco Pharmaceutical Laboratories 0 None
2009-08-29 Office of Orphan Products Development of the FDA grants Orphan Drug Designation to Quinazoline495 0 None
2009-08-29 Genzyme’s supplemental NDA for treating adult AML with Clolar to be discussed by the FDA 0 None
2009-08-29 FDA approves Watson Pharmaceuticals' ANDA for Levonorgestrel tablets 0 None
2009-08-28 Milestone reached in Biotie Wyeth collaboration for the development of PDE10 inhibitors for schizophrenia 0 None
2009-08-28 New report on the world market for biogenerics is available from Reportlinker 0 None
2009-08-28 U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin 0 None
2009-08-28 Sagent Pharmaceuticals adds fluconazole injection to its line of premixed bags 0 None
2009-08-28 Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia 0 None
2009-08-28 Elorac offers Zithranol-RR for treating plaque psoriasis 0 None
2009-08-28 AVANIR raises funds to develop and commercialize Zenvia for PBA 0 None
2009-08-28 Fast Forward selects IntraLinks to support its funding effort 0 None
2009-08-28 Kamada finalizes agreement for the distribution of its intravenous alpha-1 antitrypsin in the United States 0 5
2009-08-28 Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures 0 None
2009-08-27 Report on Chinese markets for antibiotics available from Reportlinker 0 None
2009-08-27 Mylan Pharmaceuticals markets FDA approved first generic version of Sanofi Aventis' BenzaClin 0 4
2009-08-27 China could become the fifth largest drug market by 2010-11 0 None
2009-08-27 Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND 0 3
2009-08-27 Market report evaluating the global market opportunity for transdermal pain management from Research And Markets 0 None
2009-08-27 Report on the top 10 pharmaceutical companies in India from Research And Markets 0 3
2009-08-27 Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis 0 None
2009-08-27 Viral Genetics cautions investors and the public to rely only on its own releases and disclosures 0 None
2009-08-27 European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol 0 None
2009-08-27 Prescription Solutions launches consumer website that features updated content and drug pricing tool 0 5
2009-08-27 XenaCare Holdings to market Cobroxin pain reliever drug in U.S. 0 None
2009-08-27 European Medicines Agency accepts reviewal of Merck's MAA for regulatory approval of vernakalant IV 0 None
2009-08-27 Rizer XL's male enhancement formula increases sexual desire, pleasure and performance 2 None
2009-08-27 QRxPharma completes its pilot evaluation study investigating the efficacy of MoxDuo capsules 0 5
2009-08-27 Walgreens collaborates with Caterpillar to provide transparent prescription drug pricing for employers 0 None
2009-08-27 FDA advisory panel recommends ban of pain medications Vicodin and Percocet 2 1
2009-08-26 New over-the-counter eye drop provides relief to seven symptoms of eye irritation 0 None
2009-08-26 Endo Pharmaceuticals gets exclusive rights to commercialize ProStrakan's FORTESTA in the U.S. 0 None
2009-08-26 UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies 0 None
2009-08-26 Endo Pharmaceuticals Solutions announces the beginning of cash tender offer 0 None
2009-08-26 USP and FEUM agrees to collaborate on the development of standards for medicines 0 None
2009-08-26 DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues 0 None
2009-08-26 Modest decline for hypertension drug industry over the next decade 0 None
2009-08-26 FDA to review Acorda Therapeutics’ NDA for Fampridine-SR 0 4.7
2009-08-26 FDA accepts Labopharm's response for its novel trazodone formulation 0 5
2009-08-26 Sabril (vigabatrin) Oral Solution receives approval from FDA 0 None
2009-08-26 Glaxosmithkline affirms safety of Alli 0 None
2009-08-26 Study on effectiveness of CareFusion's ChloraPrep patient preoperative skin preparation published 0 None
2009-08-26 FDA issues warning letters to eight companies for selling illegal OTC ibuprofen drugs 0 None
2009-08-26 Gloucester Pharmaceuticals raises funds for the development of romidepsin 0 None
2009-08-26 Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology 0 None
2009-08-26 Hiberix receives accelerated approval from FDA to overcome nationwide shortage 0 None
2009-08-25 ParagonRx's CEO recommends techniques to effectively manage the FDA-mandated REMS program 0 None
2009-08-25 Gastrointestinal (Stomach) Cancer Therapy Area Pipeline report available from Research and Markets 0 None
2009-08-25 Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke 0 None
2009-08-25 PerkinElmer launched its second Good Manufacturing Practice facility for radiosynthesis of potential drug compounds 0 None
2009-08-25 Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine 0 None
2009-08-25 FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets 0 None
2009-08-25 Portola Pharmaceuticals' investigational antiplatelet drug elinogrel featured at the ESC Congress 2009 0 5
2009-08-25 Blue Spoon outlines a new strategy for pharmaceutical industries 0 None
2009-08-25 Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval 0 None
2009-08-25 Lpath achieves one of the four Phase 1 objectives by demonstrating its optimized fermentation process 0 None
2009-08-25 Pharmacy Times serves as a go-to resource for pharmacists on OTC products 0 None
2009-08-25 FDA issues final approval for manufacturing and marketing Ranbaxy's Glycopyrrolate tablets 0 None
2009-08-25 Thyretain TSI Reporter BioAssay test for detecting auto-antibodies attains the FDA clearance 0 None
2009-08-25 Myoderm expands its portfolio to include drug procurement, management and distribution services 0 None
2009-08-25 UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children 0 4.5
2009-08-25 FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP 0 None
2009-08-25 NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug 0 None
2009-08-25 FDA issues warning letter to Cambrex concerning its Italian API manufacturing facility 0 None
2009-08-24 Bioniche Life Sciences update on Phase III clinical program for evaluating Urocidin 0 None
2009-08-24 WHO appeals for donated, low-cost H1N1 vaccines 0 None
2009-08-24 Orphan drug status granted to BioCancell's BC-819 drug 0 None
2009-08-24 P&G's global pharmaceuticals business sold to Warner Chilcott for $3.1 billion 0 None
2009-08-24 Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders 0 None
2009-08-24 Osteologix announces receipt of Decision to Grant a Patent from JPO for NB S101 osteoporosis drug candidate 0 None
2009-08-24 Simcere to collaborate with Sun Yat-Sen University Cancer Center to research and develop anti-cancer drugs 0 None
2009-08-24 Phase 2 clinical study of Resolvin RX-10045 for dry eye syndrome provides positive data 0 None
2009-08-24 PLoS Medicine's editors to eventually stamp ghostwriting 0 None
2009-08-24 NovaBay Pharmaceuticals to deliver two poster presentations describing results from new studies of NVC-422 0 None
2009-08-24 Cell Therapeutics' NDA for Pixantrone accepted by the FDA 0 None
2009-08-24 Biovail enters into an agreement with Santhera to develop and market JP-1730/fipamezole drug 0 None
2009-08-24 Simcere Pharmaceutical Group's forty-two generic drugs included in China's Essential Drug List 0 None
2009-08-24 Pharmaceutical manufacturers increase lobbying 0 None
2009-08-24 Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer 0 5
2009-08-24 Lundbeck to launch Sabril in the US following FDA's NDA approval 0 None
2009-08-24 Biovail's patent infringement lawsuit against Cary Pharma may affect IntelGenx revenues 0 None
2009-08-23 FDA issues complete response letter regarding the NDA for carisbamate 0 None
2009-08-22 Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug 0 None
2009-08-21 Cortex Pharmaceuticals receives delisting notification from NYSE Amex 0 None
2009-08-21 FDA approves Epocal's new glucose test on the epoc Blood Analysis System 0 None
2009-08-21 Nutra Pharma launches Cobroxin for chronic pain relief 0 None
2009-08-21 Takeda Canada reacquires commercial rights for an oral type 2 diabetic treatment drug 0 2
2009-08-21 Syntagon to deliver presentation on controlling genotoxic impurities 0 None
2009-08-21 Medicago and Ajanta Pharma forge MoU to commercialize seasonal influenza VLP-based vaccines in India 0 None
2009-08-21 New antimalarial drug discovery project funded by European Commission 0 None
2009-08-21 Newspapers examine debate over affordable drugs in developing countries 0 None
2009-08-21 U.S District Court grants preliminary approval for the settlement of Sampson v. Robinson case 0 None
2009-08-21 Health Canada approves Anika Therapeutics' MONOVISC drug 0 None
2009-08-21 Influenza A H1N1 Real Time RT-PCR tests detect RNA of H1N1 influenza virus 0 None
2009-08-21 AMDL Diagnostics to focus on in vitro diagnostic cancer tests 0 None
2009-08-20 Federal guidelines for seasonal and swine flu vaccines questioned 0 None
2009-08-20 Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study 0 2
2009-08-20 Consumer groups urge transparency in health care reform for pharmacy benefit managers 0 None
2009-08-20 Cambodia's maternal mortality; drugs in Uganda; cholera risk in Zimbabwe; HIV laws in Niger 0 None
2009-08-20 Chemical components of elderberry, cinnamon and green tea extracts block HIV viruses from infecting cells 0 4.5
2009-08-20 Advaxis awarded $210,000 for development of a dual antigen vaccine 0 None
2009-08-20 Seasonal flu vaccinations to cost less in Safeway's U.S. Stores 0 None
2009-08-20 RBC Life Sciences reports on patent-pending, nutritional supplement 0 5
2009-08-20 Wraser purchases Trezix oral capsule product from e5 Pharma 0 5
2009-08-20 Aton Pharma markets preservative-free drugs for glaucoma 0 None
2009-08-20 Imagenetix announces retail distribution of InflameAway Celadrin(R) gels for promoting joint health 0 None
2009-08-19 Phrma brushes off Republican leader's attacks 0 None
2009-08-19 FDA approves Hiberix Haemophilus influenzae type b vaccine 0 None
2009-08-19 Mylan files lawsuit against Pittsburgh Post-Gazette, Post-Gazette reporters 0 5
2009-08-19 The Gambia introduces pneumococcal immunisation programme 0 None
2009-08-19 AstraZeneca Canada files a New Drug Submission (NDS) for FluMist in Canada 0 None
2009-08-19 H1N1 vaccine orders top 1 billion, WHO Says 0 None
2009-08-19 U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals 0 4
2009-08-19 Omnia Biologics and Aparna Biosciences sign agreement on lentivirus drug development 0 None
2009-08-19 CEL-SCI expands work on current H1N1 virus vaccine 1 None
2009-08-19 Light-activated delivery system enhances anti-tumour drug potency 0 None
2009-08-19 Orient Pharma granted commercialization rights for a drug candidate by DURECT 0 None
2009-08-19 BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA 0 None
2009-08-19 CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility 0 None
2009-08-19 New production technology to develop vaccine for norovirus 0 5
2009-08-19 SFDA approves China Pharma Holdings' generic Omeprazole Sodium injection 0 None
2009-08-19 FDA places Geron Corporation's IND for spinal cord injury on clinical hold 0 4.9
2009-08-19 Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate 0 None
2009-08-18 Gloucester Pharma announces FDA Advisory Committee Meeting to discuss Romidepsin NDA 0 None
2009-08-18 Labopharm comments on outcome of patent-infringement litigation initiated by Purdue Pharma 0 None
2009-08-18 Par Pharmaceutical wins in Ultram ER litigation 0 None
2009-08-18 Synco Bio to manufacture Versartis type 2 diabetes drug candidate 0 None
2009-08-17 Boehner blasts Phrma on deal with White House 0 None
2009-08-17 FDA approves Helixate FS for routine prophylaxis in children with hemophilia A 0 None
2009-08-17 Alpharx completes lyophilization process for Zysolin 0 None
2009-08-17 GSK starts testing H1N1 vaccine; Opinion piece addresses U.S. role in helping developing countries procure vaccine 0 None
2009-08-17 FDA approves Extavia for multiple sclerosis 0 None
2009-08-17 Astronauts test nutritional supplement formulas in space 0 5
2009-08-14 Mylan Pharmaceuticals receives final FDA report on Morgantown, W.Va., manufacturing facility 0 None
2009-08-13 CVS Caremark announces results of 2009 Health IQ study 0 None
2009-08-13 Sigma-Aldrich offers customizable synthetic extracellular matrix (ECM) for stem cell research 0 None
2009-08-13 Stanford researchers want FDA to require drug makers to state how new medications compare with similar, existing treatments 0 None
2009-08-12 Dynavax announces European development strategy for investigational adult hepatitis B vaccine in Europe 0 None
2009-08-12 Bristol-Myers Squibb announces Hart-Scott-Rodino Review period for Medarex acquisition expired 0 None
2009-08-12 Nanoviricides herpes study discussed on CBS News report 4 4
2009-08-12 Health Canada approves Multaq (Dronedarone) for atrial fibrillation 2 3
2009-08-12 Forest Labs and Astrazeneca to co-develop and commercialize ceftaroline 0 None
2009-08-12 Providers, patients in States face budget squeeze 0 None
2009-08-12 Schering-Plough announces agreement with Orchid Chemicals & Pharmaceuticals on generic forms of CLARINEX 0 None
2009-08-12 Ranbaxy receives approval to market Sumatriptan Succinate tablets 0 None
2009-08-12 Scientists discover how new drug kills roundworms 0 None
2009-08-11 Labopharm submits response to FDA for formulation of the antidepressant trazodone 0 None
2009-08-11 Teva announces approval of Oxaliplatin injection 0 None
2009-08-11 Hospira launches generic version of Sanofi-Aventis' Eloxatin 0 None
2009-08-11 Britain's first swine flu vaccine trials start 0 None
2009-08-11 New type of anti-clotting drug called Apixaban 0 None
2009-08-11 PTC Therapeutics achieves milestone in Schering-Plough hepatitis C collaboration 0 None
2009-08-11 Upstream Biosciences actively seeking licensors or acquirers for anti-parasitic drug discovery portfolio and cancer diagnostic platform 0 5
2009-08-11 Seattle Genetics reaches milestone under collaboration agreement with MedImmune 0 None
2009-08-11 Easy-to-swallow drug restores autoimmune function in diabetics 0 None
2009-08-11 Genzyme updates on Cerezyme supply plus 2009 financials 0 None
2009-08-10 Mylan receives FDA approval for generic Imitrex 0 None
2009-08-10 Cephalon, Inc. completes acquisition of Arana Therapeutics 0 None
2009-08-10 CDC expands existing vaccine distribution partnership with Mckesson to include H1N1 flu vaccine 0 None
2009-08-10 Vion Pharmaceuticals announces ODAC meeting for lead oncology therapeutic Onrigin 0 None
2009-08-10 Automated dispensing unit provides more accurate pharmacy automation 0 None
2009-08-10 Nanoviricides anti-herpes drug candidate reduces viral load by 99.99% 2 2
2009-08-10 ISI to host eSolutions Conference in September 2009 0 None
2009-08-10 Sharing prescription advice among adolescents can have dangerous repercussions 0 None
2009-08-10 FDA approves APP Pharmaceuticals' Idarubicin HCI injection 0 None
2009-08-09 Expert available on recent FDA analysis of TNF blockers 0 None
2009-08-09 Watson recalls one lot of Fentanyl transdermal system 0 None
2009-08-09 Hard To Treat Diseases (HTDS) Chile flu vaccine tender 0 5
2009-08-07 Sanofi Pasteur submits supplemental application for influenza A(H1N1) 2009 monovalent vaccine to FDA 0 None
2009-08-07 White House deal with drug industry sparks Democratic revolt 0 None
2009-08-07 Clinton Foundation reaches deal with Matrix, Pfizer to cut prices for second-line Arvs, TB drug 0 None
2009-08-07 Merck shareholders overwhelmingly approve merger with Schering-Plough 0 None
2009-08-07 H1N1 vaccine will be approved, ready for use by September, WHO says 0 None
2009-08-07 American Oriental Bioengineering launches new product for rhinitis and allergies 0 None
2009-08-06 Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome 0 None
2009-08-06 Obama to drug industry: We still have a deal 0 None
2009-08-06 Celera and Aurora to collaborate on cardiovascular genetics 0 None
2009-08-06 Bill Clinton, Pfizer, and Mylan announce new agreements to lower prices of antiretrovirals for HIV/AIDS in the developing world 0 None
2009-08-06 Fast-tracked H1N1 vaccines will not compromise safety, WHO says 0 None
2009-08-06 Spectrum Pharmaceuticals acquires rights and IP for Renazorb 0 None
2009-08-06 Research details role of galectin-3 in heart failure 0 None
2009-08-06 Alnylam and Tekmira to collaborate on RNAi therapeutics 0 None
2009-08-06 Phytomedical partners with LATITUDE Pharmaceuticals on lead anti cancer compound for glioblastoma 0 None
2009-08-06 Innexus Biotechnology announces business development initiative on lead preclinical candidate 0 None
2009-08-06 Orexo: Abstral NDA submitted to U.S. FDA 0 None
2009-08-06 Genzyme’s Mozobil approved in Europe 0 None
2009-08-06 Biochemics and Pacific Pharmaceutical to collaborate on skin products 0 None
2009-08-05 Appeals court affirms invalidation of Yasmin patent 0 None
2009-08-05 Innovative diabetes drug discovery partnership 0 None
2009-08-05 Baxter completes production of batches of CELVAPAN A/H1N1 pandemic vaccine 0 2
2009-08-05 Impax Labs receives FDA approval for generic version of Depakote 0 None
2009-08-05 Epicept files NDA for Ceplene in Canada 0 None
2009-08-04 New understanding on Gleevec's limitations 0 5
2009-08-04 Evidence of Malaria origins, could lead to vaccine development 0 None
2009-08-04 Tuberculosis drugs under development could have large impact on the disease 0 None
2009-08-03 FDA approves Livalo (pitavastatin), a new cholesterol-lowering drug 0 3.9
2009-08-03 Dysport, an anti-wrinkle alternative to Botox 0 None
2009-08-03 Comp. effectiveness promises better, cheaper health care but cricits link it to rationing 0 None
2009-08-03 House panel passes protection for drug makers 0 None
2009-08-03 FDA approves Avastin plus interferon-alfa for people with metastatic renal cell carcinoma 0 None
2009-08-03 US FDA approves Lipsovir for cold sores 0 None
2009-08-02 FDA approves Invega Sustenna for schizophrenia 2 5
2009-08-02 FDA approves Onglyza (saxagliptin) for type 2 diabetes 0 None

Total

217 posts
17 comments
78 raters